Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy

Wei JIANG; Qiu-Yue CAI; Zhang-Fang LI; Zhi-Yi CHEN; Yao-Sheng LUO; Shi-di HU; Jie SHEN.
Journal of Southern Medical University ; (12): 640-645, 2017.
Artículo en Zh | WPRIM | ID: wpr-273710

Documentos relacionados

  1. [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy].
  2. The Clinical and Radiologic Features Affecting the Ocular Symptoms in Patients With Paranasal Sinus Mucoceles Involving the Orbit.
  3. Case Report: Conjunctival Chemosis as a Presenting Sign of Plasmablastic Lymphoma in an HIV-negative Patient.
  4. The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy.
  5. A comparison of proptosis reduction with teprotumumab versus surgical decompression based on fat-to-muscle ratio in thyroid eye disease.
  6. Quantitative Assessment of Orbital Decompression Surgery Using Photogrammetric Stereoimaging.
  7. Ophthalmic Presentation and Outcomes for Malignant Sinonasal Tumors.
  8. Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease.
  9. Normative Exophthalmometry Measurements Vary Among Ethiopian Adults and the Major Ethiopian Ethnic Groups.
  10. Rehabilitative orbital decompression for Graves' orbitopathy: results of a randomized clinical trial.